Gf Fund Management Co. Ltd. Bridge Bio Pharma, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.26 Trillion
- Q1 2025
A detailed history of Gf Fund Management Co. Ltd. transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 4,839 shares of BBIO stock, worth $204,109. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,839
Previous 3,968
21.95%
Holding current value
$204,109
Previous $109 Million
53.64%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$930 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$812 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$628 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$525 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$302 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.25B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...